AAV-eCD4-Ig vaccine (Scripps Research Institute)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV-eCD4-Ig vaccine (Scripps Research Institute)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Recombinant vector vaccine +[4]

Mechanisms of ActionC-C chemokine receptor type 5 modulatorsT-cell surface antigen CD4 modulators

TargetsC-C chemokine receptor type 5T-cell surface antigen CD4

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThe Scripps Research Institute Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Scripps Research Institute Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A